Total neoadjuvant FOLFIRINOX in patients with resectable locally advanced gastric and gastroesophageal junction cancer: Updated survival results

被引：0
|
作者：
Sedova, M. [1 ]
Batov, M. [1 ]
Kolomeytseva, A. [1 ]
Khomyakov, V. [2 ]
Volchenko, N. [3 ]
Fedenko, A. A. [4 ]
Kaprin, A. [5 ]
机构：
[1] PA Hertsen Moscow Oncol Res Inst, Chemotherapy, Moscow, Russia
[2] PA Hertsen Moscow Oncol Res Inst, Thoracoabdominal Oncosurg, Moscow, Russia
[3] PA Herzen Moscow Res Oncol Inst Mosc, Oncomorphol, Moscow, Russia
[4] PA Hertsen Moscow Oncol Res Inst, Div Med Oncol, Moscow, Russia
[5] PA Herzen Moscow Res Oncol Inst, Minist Hlth Russian Federat, Natl Med Res Radiol Ctr NMRRC, Moscow, Russia
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.341
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
428P
引用
收藏
页码：S173 / S174
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant versus Postoperative Chemoradiotherapy is Associated with Improved Survival for Patients with Resectable Gastric and Gastroesophageal Cancer
    Kim, Daniel W.
    Lee, Grace
    Hong, Theodore S.
    Li, Guichao
    Horick, Nora K.
    Roeland, Eric
    Keane, Florence K.
    Eyler, Christine
    Drapek, Lorraine C.
    Ryan, David P.
    Allen, Jill N.
    Berger, David
    Parikh, Aparna R.
    Mullen, John T.
    Klempner, Sam J.
    Clark, Jeffrey W.
    Wo, Jennifer Y.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 242 - 252
  • [22] Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
    Ferrone, Cristina R.
    Marchegiani, Giovanni
    Hong, Theodore S.
    Ryan, David P.
    Deshpande, Vikram
    McDonnell, Erin I.
    Sabbatino, Francesco
    Santos, Daniela Dias
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Faris, Jason E.
    Goyal, Lipika
    Kwak, Eunice L.
    Murphy, Janet E.
    Ting, David T.
    Wo, Jennifer Y.
    Zhu, Andrew X.
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Fernandez-del Castillo, Carlos
    ANNALS OF SURGERY, 2015, 261 (01) : 12 - 17
  • [23] Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer
    Iden, Cecilie Riis
    Mustafa, Salah Mohammad
    Ogaard, Nadia
    Henriksen, Tenna
    Jensen, Sarah Ostrup
    Ahlborn, Lise Barlebo
    Egebjerg, Kristian
    Baeksgaard, Lene
    Garbyal, Rajendra Singh
    Nedergaard, Mette Kjolhede
    Achiam, Michael Patrick
    Andersen, Claus Lindbjerg
    Mau-Sorensen, Morten
    GASTRIC CANCER, 2025, 28 (01) : 83 - 95
  • [24] Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
    Ratosa, Ivica
    Oblak, Irena
    Anderluh, Franc
    Velenik, Vaneja
    But-Hadzic, Jasna
    Ermenc, Ajra Secerov
    Jeromen, Ana
    RADIOLOGY AND ONCOLOGY, 2015, 49 (02) : 163 - 172
  • [25] Neoadjuvant Treatment Strategies for Resectable Proximal Gastric, Gastroesophageal Junction and Distal Esophageal Cancer
    Ahmad, M. Usman
    Javadi, Christopher
    Poultsides, George A.
    CANCERS, 2022, 14 (07)
  • [26] Survival outcomes in patients with resectable gastric cancer treated with total neoadjuvant therapy.
    Song, Yun
    Hirata, Yuki
    Ajani, Jaffer A.
    Murphy, Mariela A. Blum
    Li, Jenny Jing
    Das, Prajnan
    Minsky, Bruce D.
    Mansfield, Paul F.
    Ikoma, Naruhiko
    Badgwell, Brian D.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 338 - 338
  • [27] Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX
    Choi, Jin Ho
    Kim, Min Kyu
    Lee, Sang Hyub
    Park, Jin Woo
    Park, Namyoung
    Cho, In Rae
    Ryu, Ji Kon
    Kim, Yong-Tae
    Jang, Jin-Young
    Kwon, Wooil
    Kim, Hongbeom
    Paik, Woo Hyun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] OPTIMAL ADJUVANT THERAPY IN PATIENTS WITH BORDERLINE RESECTABLE AND LOCALLY ADVANCED PANCREATIC CANCER WHO HAD RECEIVED NEOADJUVANT FOLFIRINOX
    Choi, Jin Ho
    Kim, Min Kyu
    Lee, Sang Hyub
    Park, Namyoung
    Kim, Jung
    Cho, In Rae
    Ryu, Ji Kon
    Kim, Yong-Tae
    Paik, Woo Hyun
    GASTROENTEROLOGY, 2022, 162 (07) : S741 - S741
  • [29] Locally advanced gastroesophageal junction cancer: Neoadjuvant treatment with VMAT and concomitant chemotherapy
    Tozzi, A.
    Iftode, C.
    Comito, T.
    Campisi, M. C.
    Navarria, P.
    Clerici, E.
    Maggi, G.
    Mancosu, P.
    Stravato, A.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S69 - S69
  • [30] Influence of neoadjuvant regimen on the prognosis of locally advanced gastric and gastroesophageal junction cancer with HER2 overexpression
    Zhao, Lingdi
    Liu, Xiao
    Chen, Guanglong
    Ma, Baozhen
    Huang, Jinxi
    Jiang, Zhiqiang
    Hou, Xinfang
    Li, Ning
    Qin, Peng
    Zhang, Yong
    Wang, Zibing
    Li, Zhi
    Gao, Quanli
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345